Texas Biotechnology receives argatroban approval

The FDA granted marketing approval to TXB and partner SmithKline Beecham (SBH; LSE:SB) for argatroban to prevent or treat thrombosis associated with heparin-induced thrombocytopenia (HIT). TXB develop...